Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Bharat Biotech’s Covaxin shows 77.8% efficacy in phase III trials

Agencies
Updated: June 22nd, 2021, 18:37 IST
in Coronavirus, National, Prime News, Sci-Tech
0
Covaxin
Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

New Delhi: Bharat Biotech’s Covaxin is 77.8 per cent effective in protecting against Covid-19, according to data from Phase III trials conducted on 25,800 participants across India. Sources said trial data and results of Covaxin were studied and recommended for approval by the DCGI’s Subject Expert Committee, Tuesday. The data was submitted to the DCGI over the weekend. The data has not yet been published in an internationally recognised, peer-reviewed journal; earlier this month Bharat Biotech said publication would only happen after submission to the regulator.

‘First interim analysis’ of Phase III results, presented in March, indicated Covaxin was 81 per cent effective in preventing Covid-19 in those without prior infection after the second dose. Data available and analysed at that stage also showed a 100 per cent reduction in chances of hospitalisation in case of infection.

Also Read

India-Japan ties

India, Japan to accelerate cooperation in underwater, missile technologies

2 hours ago
BJP targets Rahul Gandhi over 'sick' remark on Indian democracy

BJP targets Rahul Gandhi over ‘sick’ remark on Indian democracy

4 hours ago

Phase III data approval will likely also help Bharat Biotech secure an EUL (emergency use listing) from the World Health Organisation (WHO).

The company is expected to hold a ‘pre-submission’ meeting with WHO authorities Wednesday, to discuss guidelines for final submission of required data and documents. Sources said that Bharat Biotech had already submitted 90 per cent of the required paperwork. Last month Bharat Biotech said it expected to get WHO approval for Covaxin by September.

An EUL from WHO will allow the company to export Covaxin and enable easier international travel for Indians vaccinated with the drug, which is not yet recognised by some foreign governments.

Covaxin was cleared for emergency use last year while still in clinical trials; it was given ‘restricted use in emergency situation in public interest’.

Approved Phase III data will go help resolve doubts as the government looks to increase pace of vaccination to prep for a likely third wave and protect against mutated versions of the virus.

 

Tags: Bharat BiotechCovaxinDCGITrialsVaccinationWHO
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Debasis Mohanty

December 12, 2019
#MyPaperBagChallenge

Vandana Singh

December 12, 2019
#MyPaperBagChallenge

Matrumangal Jena

December 12, 2019
#MyPaperBagChallenge

Adyasha Priyadarsani Sendha

December 12, 2019
#MyPaperBagChallenge

Sarfraz Ahmad

December 12, 2019
#MyPaperBagChallenge

Adrita Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Tabish Maaz

December 12, 2019
#MyPaperBagChallenge

Priyasha Pradhan

December 12, 2019
#MyPaperBagChallenge

Swarit Praharaj

December 12, 2019
#MyPaperBagChallenge

Sarmistha Nayak

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Rajashree Pravati Mohanty

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Faiza Firdous

December 12, 2019
#MyPaperBagChallenge

Aman Kumar Barisal

December 12, 2019
#MyPaperBagChallenge

Anup Mahapatra

December 12, 2019
#MyPaperBagChallenge

Pratik Kumar Ghibela

December 12, 2019
#MyPaperBagChallenge

Sitakanta Mohanty

December 12, 2019
#MyPaperBagChallenge

Archana Parida

December 12, 2019
#MyPaperBagChallenge

Praptimayee Biswal

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Sisirkumar Maharana

December 12, 2019
#MyPaperBagChallenge

Narendra Kumar

December 12, 2019
#MyPaperBagChallenge

Diptiranjan Biswal

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019

Archives

Editorial

Tech Terror

November 18, 2026

It cannot be a coincidence that when the world was still trying to come to terms with the prospect of...

Read moreDetails

More Miseries Ahead

Inflation in India
November 17, 2026

Life is getting difficult by the day for Indians with all us citizens reeling under the dual shocks of rising...

Read moreDetails

Tough Times

Press
November 16, 2026

Press freedom has, for years, been under attack almost everywhere across the globe, but the situation has never been as...

Read moreDetails

Democracy Strikes Back

Rights & Restrictions: AAKAR PATEL
November 15, 2026

By Aakar Patel Democracies correct themselves through elections. The leadership of every nation is imperfect, and the problems become especially...

Read moreDetails
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2025 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2025 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2025 All rights Reserved by OrissaPOST